Cairns D - Search Results

1

Modulation of [3H] TBOB binding to the rodent GABAA receptor by simple disaccharides.

Rezai N, Duggan C, Cairns D, Lees G, Chazot PL. Rezai N, et al. Among authors: cairns d. Biochem Pharmacol. 2003 Feb 15;65(4):619-23. doi: 10.1016/s0006-2952(02)01611-8. Biochem Pharmacol. 2003. PMID: 12566090

2

Potential transition state phosphoramidate inhibitors of beta-tubulin as antifilarial agents.

Anderson RJ, Bendell DJ, Hooper M, Cairns D, Mackay SP, Hiremath SP, Jivanagi AS, Badami S, Biradar JS, Townson S. Anderson RJ, et al. Among authors: cairns d. J Pharm Pharmacol. 2001 Jan;53(1):89-94. doi: 10.1211/0022357011775055. J Pharm Pharmacol. 2001. PMID: 11206197

3

Anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription.

Gibson V, Anderson RJ, Hartley JA, McAdam SR, Cairns D. Gibson V, et al. Among authors: cairns d. J Pharm Pharmacol. 2000 Jun;52(6):599-602. doi: 10.1211/0022357001774426. J Pharm Pharmacol. 2000. PMID: 10875534

4

Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase.

Cairns D, Michalitsi E, Jenkins TC, Mackay SP. Cairns D, et al. Bioorg Med Chem. 2002 Mar;10(3):803-7. doi: 10.1016/s0968-0896(01)00337-6. Bioorg Med Chem. 2002. PMID: 11814869

5

Design of telomerase inhibitors for the treatment of cancer.

Cairns D, Anderson RJ, Perry PJ, Jenkins TC. Cairns D, et al. Curr Pharm Des. 2002;8(27):2491-504. doi: 10.2174/1381612023392720. Curr Pharm Des. 2002. PMID: 12369943 Review.

6

A potential new prodrug for the treatment of cystinosis: design, synthesis and in-vitro evaluation.

McCaughan B, Kay G, Knott RM, Cairns D. McCaughan B, et al. Among authors: cairns d. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1716-9. doi: 10.1016/j.bmcl.2008.01.039. Epub 2008 Jan 18. Bioorg Med Chem Lett. 2008. PMID: 18249536

7

Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis.

Omran Z, Moloney KA, Benylles A, Kay G, Knott RM, Cairns D. Omran Z, et al. Among authors: cairns d. Bioorg Med Chem. 2011 Jun 1;19(11):3492-6. doi: 10.1016/j.bmc.2011.04.022. Epub 2011 Apr 16. Bioorg Med Chem. 2011. PMID: 21536447

8

PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis.

Omran Z, Kay G, Di Salvo A, Knott RM, Cairns D. Omran Z, et al. Among authors: cairns d. Bioorg Med Chem Lett. 2011 Jan 1;21(1):45-7. doi: 10.1016/j.bmcl.2010.11.085. Epub 2010 Nov 21. Bioorg Med Chem Lett. 2011. PMID: 21147534

9

Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis.

Omran Z, Kay G, Hector EE, Knott RM, Cairns D. Omran Z, et al. Among authors: cairns d. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2502-4. doi: 10.1016/j.bmcl.2011.02.048. Epub 2011 Feb 23. Bioorg Med Chem Lett. 2011. PMID: 21397500

10

Small molecule kinase inhibitors as anti-cancer therapeutics.

Chahrour O, Cairns D, Omran Z. Chahrour O, et al. Among authors: cairns d. Mini Rev Med Chem. 2012 May;12(5):399-411. doi: 10.2174/138955712800493915. Mini Rev Med Chem. 2012. PMID: 22303944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters